Cho SW, et al. - Researchers analyzed the effect of extended clopidogrel therapy on long-term clinical outcomes in patients with diabetes mellitus (DM) who received a second-generation drug-eluting stent (DES). Landmark analysis among 1,600 patients after second-generation DES implantation who were event-free at 12 months after the index procedure, revealed that compared to non-diabetic patients, diabetic patients receiving second-generation DES implantation demonstrate more prominent benefits of extended clopidogrel therapy.